Rabies, The Administration of Vaccines and Public Health Concern, Neglected Challenges and Historical Perspective in China

Yıl 2024, Cilt: 7 Sayı: 6, 267 - 282, 15.11.2024

Mohamad Hesam Shahrajabian , Wenli Sun

https://doi.org/10.19127/bshealthscience.1507563

Öz

Rabies virus is transmitted via contact of saliva of a rabid animal with a persons’ mucosa or a skin lesion. It is a fatal encephalomyelitis caused by members of expanding Lyssavirus genus, and the genus included 17 species. The aim of this literature review is to survey on rabies and vaccination in China, threats and challenges to eliminate it, especially in China. The information provided is obtained from randomized control experiments, review articles, and analytical observations and studies which were gathered from various literature sources such as Scopus, Google Scholar, PubMed, and Science Direct. Rabies virus is a bullet shaped enveloped virion, and the classical rabies virus and its field strains are discovered worldwide and induces to rabies in animals and humans. In recent years, China has made wonderful and significant achievements in rabies prevention and control, and currently, the mortality and incidence rate of human infection with rabies have decreased to the minimum level historically, which has caused a notable foundation for the ultimate elimination of human rabies. Generally, five proteins are available in mature rabies virus (RABV) particles, phosphoprotein, nucleoprotein, glycoprotein, matrix protein, and RNA-dependent RNA polymerase. The main carriers of rabies in China are dogs which are accountable for most of the human rabies deaths in China. Most common way of entry of rabies virus into the body is both via infected neural tissue through open cuts in the skin and salvia. Rabies remain a public health problem and continue to present health risks for both animals and human; It is important to improve access to post-exposure prophylaxis (PEP) in endemic countries where human rabies deaths still happen, but the big problem is its costs that should be curtailed and surveillance strengthened for controlling and eliminating it.

Anahtar Kelimeler

Dogs, Glycoprotein, Lyssavirus, Post-exposure prophylaxis, Rabies virus

Kaynakça

• Abedi M, Haftcheshmeh SM, Bashar R. 2023. Rabies vaccine: Recent update and comprehensive review of in vitro and in vivo studies. Process Biochem, 124: 201-220. https://doi.org/10.1016/j.procbio.2022.11.011
• Abela-Ridder B, Knopf L, Martin S. 2016. The beginning of the end of rabies? Lancent Glob Health, 4: e780-781.
• Abutarbsh SM, Hamdallah A, Hawawsheh M, Alsawalha L, Elizz NA, Dodeen R, Mousa AB, Alhawarat MN, Hailat E, Mahrous H. 2022. Implementation of one health approach in Jordan: Joint risk assessment of rabies and avian influenza utilizing the tripartite operational tool. One Health, 15: 100453. https://doi.org/10.1016/j.onehlt.2022.100453
• Ahmad T, Musa TH, Jin H. 2018. Rabies in Asian countries: were we are stand? Biomed Res Ther, 5(10): 2719-2720.
• Aiello R, Zecchin B, Caenazzo ST, Cattoli G, De Benedictis P. 2016. Disinfection protocols for necropsy equipment in rabies laboratories: Safety of personnel and diagnostic outcome. J Virol Meth, 234: 75-79. https://doi.org/10.1016/j.jviromet.2016.03.017
• Anilionis WH, Wunner PJ. 1981. Curtis, Structure of the glycoprotein gene in rabies virus. Nature, 294: 275-278.
• Anothaisintawee T, Genuino AJ, Thavorncharoensap M. 2019. Cost-effectiveness modeling studies of all preventive measures against rabies: a systematic review. Vaccine, 37: A146-A153.
• ASEAN. 2015. ASEAN Rabies Elimination Strategy. OIE World Organization for Animal Health.
• Ashraf S, Singh PK, Yadav DK, Shahnawaz Md, Mishra S, Sawant SV, Tuli R. 2005. High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J Biotechnol, 119: 1-14.
• Atici YT, Oguzoglu TC. 2022. The comparison of full G and N gene sequences from Turkish rabies virus field strains. Virus Res, 315: 198790. https://doi.org/10.1016/j.virusres.2022.198790
• Bassi EJ. 2008. Expression, purification and immunodetection of a recombinant fragment (residue 179-281) of the G protein from rabies virus ERA strain. Protein Express Purif, 59: 309-313.
• Beyene K, Derese A, Teshome G, Teshome D. 2018. Review on rabies vaccine: as prevention and control option of rabies. Austin J Vet Sci Anim Husb, 5(3): 1049.
• Briggs DJ, Moore SM. 2021. The route of administration of rabies vaccines: Comparing the data. Viruses, 13: 1252. https://doi.org/10.3390/v13071252
• Buchy P, Preiss S, Singh V, Mukherjee P. 2017. Heterogeneity of rabies vaccination recommendations across Asia. Trop Med Infect Dis, 2(23): 1-17.
• Cai L, Wang L, Guan X, Wang L, Hu X, Wu Y, Tong Y, Wang P. 2021. Epidemiological analysis of rabies in central China from 2013 to 2018. Infect Drug Resis, 2753-2762. https://doi.org/10.2147/IDR.S314881
• Celis E, Ou D, Dietzschold B, Koprowski H. 1988. Recognition of rabies and rabies-related virus by T cells derived from human vaccine recipients. J Virol, 62: 3128-3134.
• Challhua R, Akashi L, Zuniga J, de Carvalho Ruthner Batista HB, Moratelli R, Champi A. 2023. Portable reduced graphene oxide biosensor for detection of rabies virus in bats using nasopharyngeal swab samples. Biosens Bioelectron, 232: 115291. https://doi.org/10.1016/j.bios.2023.115291
• Changalucha J, Steenson R, Grieve E. 2019. The need to improve access to rabies post-exposure vaccines: lessons from Tanzania. Vaccine, 37: A45-A53.
• Chen F, Liu QY, Jiang QQ, Shi J, Luba TR, Hundera AD, Fang P, Cao S, Lu Z. 2019. Risk of human exposure to animal vites in China: a clinical-based cross-sectional study. Ann N Y Acad Sci, 1452(1): 78-87. https://doi.org/10.1111/nyas.14202
• Chen R, Li H, Zhu W, Cheng H, Li Y. 2023. Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus. Expert Opin Drug Saf, 23(6): 755-762. https://doi.org/10.1080/14740338.2023.2233411
• Chen T, Zhou X, Qi Y. 2019. Feline herpesvirus vectored-rabies vaccine in cats: a dual protection. Vaccine, 37: 2224-2231.
• Cherian S, Singh R, Singh KP. 2015. Phylogenetic analysis of Indian rabies virus isolates targeting the complete glycoprotein gene. Infect Gene Evol, 36: 333-338.
• Cliquet F, Barrat J, Guiot AL. 2008. Efficacy and bait acceptance of vaccinia vectored rabies glycopteotin vaccine in captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and dogs (Canis familiaris). Vaccine, 26: 4627-4638.
• Coertse J, Viljoen N, Weyer J, Markotter W. 2023. Comparative neutralization activity of commercial rabies immunoglobulin against diverse Lyssaviruses. Vaccines, 11: 1255. https://doi.org/10.3390/vaccines11071255
• Coll JM. 1995. The glycoprotein G of rhabdoviruses. Arch Virol 140: 851-987.
• Costa WA, Cunha RS, Bolzan VL. 2007. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium. Vaccine, 25: 8140-8145.
• Cox JH, Dietzschold B, Schneider LG. 1977. Rabies virus glycoprotein II: biological and serological characterization. Infect Immunol, 16: 754-759.
• Cruz ET, Romero IAF, Mendoza JGL. 2008. Efficient post-exposure prophylaxis against rabies by applying a four-dose DNA vaccine intranasally. Vaccine, 26: 6936-6944.
• Cui H, Shahrajabian MH, Kuang Y, Zhang HY, Sun W. 2023. Heterologous expression and function of cholesterol oxidase: A review. Protein Pept Lett, 30(7): 531-540. https://doi.org/10.2174/0929866530666230525162545
• Das LJ, Isloor S, Santosh AK, Bhat A, Sharada R, Rathnamma D, Veeregowda BM, Phanşraj KL, Kumar NA, Vanak AT. 2022. A comparative evaluation of the estimation of rabies virus antibodies among free-roaming, vaccinated dogs in Bengaluru, India. Viruses, 14: 484. https://doi.org/10.3390/v14030484
• Deidda R, Orlandini S, Hubert P, Hubert C. 2018. Risk-based approach for method development in pharmaceutical quality control context: a critical review. J Pharm Biomed Anal, 161: 110-121.
• Deubelbeiss AN, Rachsel Ch, Bachli EB, Kuffer A, Budka H, Eniseyskiy P, Zimmermann H, Wallace RM, Farley S, Zanoni RG. 2013. Imported human rabies in Switzerland 2012: A diagnostic conundrum. J Clin Virol, 57(2): 178-181. https://doi.org/10.1016/j.jcv.2013.02.001
• Ding Y, Wu M, Zhang H, Zhu X, Hu Y, Li X, Liu J, Tsao E, Liu M, Li C. 2020. Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects. Antivir Res, 184: 104956. https://doi.org/10.1016/j.antiviral.2020.104956
• Diogo MM, Ribeiro SC, Queiroz JA. 2001. Production, purification and analysis of an experimental DNA vaccine against rabies. J Gene Med, 3: 577-584.
• Dong Y, Wang L, Burgner DP, Burgner DP, Miller, JE, Song Y, Ren X, Li Z, Xing Y, Ma J, Sawyer SM, Patton G. 2020. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. BMJ, 369: m1043. https://doi.org/10.1136/bmj.m1043
• Du J, Zhang Q, Tang Q, Li H, Tao X, Morimoto K, Nadin-Davis SA, Liang G. 2008. Characterization of human rabies virus vaccine strain in China. Virus Res, 135(2): 260-266. https://doi.org/10.1016/j.virusres.2008.04.002
• Duong V, Tarantola A, Ong S, Mey C, Choeung R, Ly S, Bourhy H, Dussart P, Buchy P. 2016. Laboratory diagnostics in dog-mediated rabies: an overview of performance and a proposed strategy for various settings. Int J Infect Dis, 46: 107-114. https://doi.org/10.1016/j.ijid.2016.03.016
• Echevarria J, Banyard AC, McElhinney LM, Fooks AR. 2019. Current rabies vaccine do not confer protective immunity against divergent lyssaviruses circulating in Europe. Viruses, 11: 892.
• Ertl HCJ. 2019. New rabies vaccines for use in humans. Vaccines, 7: 54. https://doi.org/10.3390/vaccines7020054
• Evans JS, Horton DL, Easton AJ, Fooks AR, Banyard AC. 2012. Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine? Vaccine, 30: 7447-7454.
• Fan L, Zhang L, Li J, Zhu F. 2022. Advances in the progress of monoclonal antibodies for rabies. Human Vaccin Immunother, 18(1): 2026713. https://doi.org/10.1080/21645515.2022.2026713
• Finke S, Conzelmann KK. 2003. Dissociation of rabies virus matrix protein functions in regulation of viral RNA synthesis and virus assembly. J Virol, 77: 12074-12082.
• Fooks AR, Banyard AC, Ertl HCJ. 2019. New human rabies vaccines in the pipeline. Vaccine, 37:A140-A145.
• Fu ZF. 1997. Rabies and rabies research: past, present and future. Vaccine, 15: S20-S24.
• Gaudin Y, Ruigrok R, Tuffereau C, Knossow A. 1997. Flamand, Rabies glycoprotein is a trimer. Virology, 187: 627-632.
• Gerard FCA, Ribeiro JrEDA, Leyrat C, Ivanov I, Blondel D, Longhi S, Ruigrok RWH, Jamin M. 2009. Modular organization of rabies virus phosphoprotein. J Mol Biol, 388: 978-996.
• Gholami A, Fayaz A, Farahtaj F. 2014. Rabies in Iran: past, present and future. J Med Microbiol Infec Dis, 2(1): 1-10.
• Gibert R, Alberti M, Poirier B, Jallet C, Tordo N, Morgeaux S. 2013. A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release. Vaccine, 31: 6022-6029.
• Gong W, Jiang Y, Za Y, Zeng Z, Shao M, Fan J, Sun Y, Xiong Z, Yu X, Tu C. 2010. Temporal and spatial dynamics of rabies viruses in China and Southeast Asia. Virus Res, 150(1-2): 111-118. https://doi.org/10.1016/j.virusres.2010.02.019
• Gongal G, Sampath G, Kishore J, Bastola A, Punrin S, Gunesekera A. 2022. The impact of Covid-19 pandemic on rabies post-exposure prophylaxis services in Asia. Human Vaccin Immunother, 18(5): 2064174. https://doi.org/10.1080/21645515.2022.2064174
• Gongal G, Wright AE. 2011. Human rabies in the WHO Southeast Asia region: forward steps for elimination. Adv Prev Med, 2011: 383870.
• Goto H, Minamoto N, Ito H, Sugiyama M, Kinjo T, Kawai A. 2000. Mapping of epitopes and structural analysis of antigenic sites in the nucleoprotein of rabies virus. J General Virol, 81: 119-127.
• Guo D, Zhou H, Zou Y, Yin W, Yu H, Si Y, Li J, Zhou Y, Zhou X, Magalhaes RJS. 2013. Geographical analysis of the distribution and spread of human rabies in China from 2005 to 2011. Plos One, 8: e72352. https://doi.org/10.1371/journal.pone.0072352
• Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, Costa P, Freuling CM, Hiby E, Knopf L, Leanes F, Meslin F-X, Metlin A, Miranda ME, Muller T, Nel LH, Recuenco S, Rupprecht CE, Schumacher C, Taylor L, Global Alliance for Rabies Control Partners for Rabies Prevention. 2015. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis, 9(4). http://doi.org/10.1371/journal.pntd.0003709e0003709.
• Hampson K, Dobson A, Kaare M, Dushoff J, Magoto M, Sindoya E, Cleaveland S. 2008. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis, 2(11): e 339.
• He Y, Gao D, Zhang M. 2006. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent. J Virol Meth, 138(1-2): 147-151. https://doi.org/10.1016/j.jviromet.2006.08.006
• Hemachudha T, Laothamatas J, Rupprecht CE. 2002. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol, 1(2): 101-109. https://doi.org/10.1016/S1474-4422(02)00041-8
• Hou Q, Jin Z, Ruan S. 2012. Dynamics of rabies epidemics and the impact of control efforts in Guuangdong province, China. J Theor Biol, 300: 39-47. https://doi.org/10.1016/j.jtbi.2012.01.006
• Hu R, Tang Q, Tang J, Fooks AR. 2009. Rabies in China: an update. Vector-Borne Zoonotic Dis, 9(1): 1-11.
• Hu RL, Liu Y, Zhang SF, Zhang F, Fooks AR. 2007. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine, 25: 5301-5307.
• Huang J, Ruan S, Shu Y, Wu X. 2019. Modeling the transmission dynamics of rabies for dog, Chinese ferret badger and human interactions in Zhejiang province, China Bull Math Bio, 81: 939-962. https://doi.org/10.1007/s11538-018-00537-1
• Huang Y, Tang Q, Nadin-Davis SA, Zhang S, Hooper CD, Ming P, Du J, Tao X, Hu R, Liang G. 2010. Development of a reverse genetic system for a human rabies virus vaccine strain employed in China. Virus Res, 149(1): 28-35. https://doi.org/10.1016/j.virusres.2009.12.009
• Itakura Y, Tabata K, Morimoto K, Ito N, Chambaro HM, Eguchi R, Otsuguro K-I, Hall WW, Orba Y, Sawa H, Sasaki M. 2022. Glu333 in rabies virus glycoprotein is involved in virus attenuation through astrocyte infection and interferon responses. iScience, 25(4): 104122. https://doi.org/10.1016/j.isci.2022.104122
• Ito N, Okamoto T, Sasaki M, Miyamoto S, Takahashi T, Izumi F, Inukai M, Jarusombuti S, Okada K, Nakagawa K, Fuji Y, Nishiyama S, Masatani T, Sawa H, Sugiyama M. 2021. Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein. Vaccine, 39(38): 3777-3784. https://doi.org/10.1016/j.vaccine.2021.05.002
• Izumi F, Miyamoto S, Masatani T, Sasaki M, Kawakami K, Takahashi T, Fujiwara T, Fujii Y, Okajima M, Nishiyama S, Sawa H, Sugiyama M, Ito N . 2023. Generation and characterization of a genetically modified live rabies vaccine strain with attenuating mutations in multiple viral proteins and evaluation of its potency in dogs. Vaccine, 41(33): 4907-4917. https://doi.org/10.1016/j.vaccine.2023.06.076
• Jochmans D, Neyts J. 2019. The path towards effective antivirals against rabies. Vaccine, 37: 4660-4662.
• Johnson SR, Slate D, Nelson KM, Davis AJ, Mills SA, Forbes JT, VerCauteren KC, Gilbert AT, Chipman RB. 2021. Serological responses of Raccoons and striped skunks to Ontario rabies vaccines bait in West Virginia during 2012-2016. Viruses, 13: 157. https://doi.org/10.3390/v13020157
• Kasem S, Hussein R, Al-Doweriej A, Qasim I, Abu-Obeida A, Almulhim I, Alfarhan H, Hodhod AA, Abel-Latif M, Hashim O, Al-Mujalli D, Al-Sahaf A. 2019. Rabies among animals in Saudi Arabia. J Infect Public Health, 12: 445-447.
• Khan A, Ayaz R, Mehtab A, Naz K, Haider W, Gondal MA, Umer M, Afzal MI, Shah NA, Afzal MS, Yayi G, Ahmad KS, Ahmed H. 2019. Knowledge, attitude and practices (KAPs) regarding rabies endemicity among the community members, Pakistan. Acta Tropica, 200: 105156.
• Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, Miranda MEG, Shaw A, Zinsstag J, Meslin F-X. 2005. Re-evaluating the burden of rabies in Africa and Asia. Int L Pub Health, 83: 360-368.
• Koraka P, Bosch BJ, Cox M, Chubet R, Amerongen GV, Lovgren-Bengtsson K, Martina BEE, Roose J, Rottier PJM, Osterhaus ADME. 2014. A recombinant rabies vaccine expression the trimeric from the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Vaccine, 32: 4644-4650.
• Koraka P, Martina BEE, Smreczak M. 2019. Inhibition of caspase-1 prolongs survival of mice infected with rabies virus. Vaccine, 37: 4681-4685.
• Laager M, Lechenne M, Naissengar K. 2019. A metapopulation model of dog rabies transmission in N,Djamena, Chad. J Theor Biol, 462: 408-417.
• Langguth A, Leelahapongsathon K, Wannapong N, Kasemsuwan S, Ortmann S, Vos A, Boer M. 2021. Comparative study of optical markers to assess bait system efficiency concerning vaccine release efficiency concerning vaccine release in the oral cavity of dogs. Viruses, 13: 1382. https://doi.org/10.3390/v13071382
• Lankester F, Hampson K, Lembo T, Palmer G, Taylor L, Cleaveland S. 2014. Implementing Pasteur,s vision for rabies elimination. Science, 345: 1562-1564.
• Lee L. 2004. The current state of public health in China. Annu Rev Pub Health, 25: 327-339.
• Li AJ, Sreenivasan N, Siddiqi UR, Tahmina S, Penjor K, Sovann L, Gunesekera A, Blanton JD, Knopf, Hyde TB. 2019. Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017-2018. Vaccine, 37: A14-A19.
• Li D, Liu Q, Chen F, Jiang Q, Wang T, Yin X, Lu Z, Cao S. 2021. Knowledge, attitudes, and practices regarding rabies and its prevention and control among bite victims by suspected rabid animals in China. One Health, 13:100264. https://doi.org/10.1016/j.onehlt.2021.100264
• Li H, Li Y, Chen Y, Chen B, Su Q, Hu Y, Xiong C. 2023. Mapping rabies distribution in China: a geospatial analysis of national surveillance data. Int J Infect Dis, 131: 140-146. https://doi.org/10.1016/j.ijid.2023.04.002
• Li L, Li Y, Bai Y, Li G, Zhang J, Yang L, Zhao W, Zhao W, Luo F, Zhao Q, Zhang Z, Liu Y, Lu Q, Wang H, Zhang J, Zhang Y, Gao J, Shi N. 2022. Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase IIb randomized, double-blind, parallel-controlled study. Vaccine, 40: 6153-6162. https://doi.org/10.1016/j.vaccine.2022.09.022
• Li R, Huang L, Li J, Mo Z, He B, Wang Y, Wu X, Minutello M, Guinet-Morlot F, Pichon S. 2013. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China. Vaccine, 31(50): 5940-5947. https://doi.org/10.1016/j.vaccine.2013.10.043
• Li W, Liu S, Qian S, Zhu J, Selvaraj JN, Zhang X. 2021. Is the rate of adverse reaction to rabies vaccine in China really as the public thinks?-based on a meta analysis. Human Vaccin Immunother, 17(3): 714-722. https://doi.org/10.1080/21645515.2020.1794218
• Li X, Luo J, Wang S, Shen Y, Qiu Y, Wang X, Deng X, Liu X, Bao W, Liu P, Zhou J, Ding C, Ma Z. 2010. Engineering, expression, and immune-characterization of recombinant protein comprising multi-neutralization sites of rabies virus glycoprotein. Protein Express Purif, 70: 179-183.
• Linscott AJ. 2012. Rabies. Clin Microbiol Newslett, 34(22): 177-180.
• Liu Q, Xiong Y, Luo TR, Wei Y-C, Nan S-J, Liu F, Pan Y, Feng L, Zhu W, Liu K, Guo J-G, Li H-M. 2007. Molecular epidemiology of rabies in Guangxi Province, south of China. J Clin Virol, 39(4): 295-303. https://doi.org/10.1016/j.jcv.2007.04.021
• Liu X, Feng X, Tang Q, Wang Z, Qiu Z, Li Y, Wang C, Feng Z, Zhu J, Guan X. 2010. Characterization and potential diagnostic application of monoclonal antibodies specific to rabies virus. J Biomed Res, 24(5): 395-403. https://doi.org/10.1016/S1674-8301(10)60053-X
• Liu X, Li Y, Li J, Zhou J, Guo J, Pu Y, Jiang Y, Zhou Y, Jiang Z, Shu Q, Wang C, Wang J, Zhao Y, Zhao W, Wang H, Wei J, Yu H, Gao J Li X. 2023. Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial. Int J Infect Dis, 134: 53-62. https://doi.org/10.1016/j.ijid.2023.05.017
• Liu Y, Chen Q, Zhang F. 2013. Evaluation of rabies biologics against irkut virus isolated in China. J Clin Microbiol, 51(11): 3499-3504.
• Liu Y, Zhang HP, Zhang SF, Wang J-X, Zhou H-N, Zhang F, Wang Y-M, Ma L, Li N, Hu R-L. 2016. Rabies outbreaks and vaccination in domestic camels and cattle in northwest China. PLoS Negl Trop Dis, 10: e0004890.
• Liu Y, Zhang S, Zhang F, Hu R. 2012. Adjuvant activity of Chinese herbal polysaccharides in inactivated veterinary rabies vaccines. Int J Biol Macromol, 50(3): 598-602. https://doi.org/10.1016/j.ijbiomac.2012.01.035
• Liu Y, Zhang S, Zhao J, Zhang F, Hu. 2013. Isolation of Irkut virus from a Murina leucogaster bat in China. PLoS NeglTrop Dis, 7: e2097.
• Liu Y, Zhang S, Zhao J, Zhang F, Li N, Lian H, Wuengege, Guo S, Hu R. 2014. Fox- and raccoon-dog-associated rabies ourbreaks in northern China. Virol Sin, 29(5): 308-310.
• Liu Y, Zhang SD, Wu XF, Zhao J, Hou Y, Zhang F, Velasco-Villa A, Rupprecht CE, Hu R. 2010. Ferret badger rabies origin and its revisited importance as potential source of rabies transmission in Southeast China. BMC Infect Dis, 10: 234. https://doi.org/10.1186/1471-2334-10-234
• Luo J, Zhang Y, He H, Liu Q, Huang S, Guo X. 2019. Artesunate enhances the immune response of rabies vaccine as an adjuvant. Vaccine, 37: 7478-7481.
• Luo Y, Zhang Y, Liu X, Yang Y, Yang X, Zheng z, Deng X, Wu X, Guo X. 2013. Characterization of a wild rabies virus isolate of porcine origin in China. Infect Gen Evol, 17: 147-152.
• Macfarlan RI, Dietzschold B, Koprowski H. 1986. Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain. Mol Immunol, 23: 733-741.
• Marmitt D, Shahrajabian MH. 2021. Plant species used in Brazil and Asia regions with toxic properties. Phytother Res, 2021(2): 1-24. https://doi.org/10.1002/ptr.7100
• Marosi A, Dufkova L, Forro B. 2019. Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin. Vaccine, 37: 4724-4735.
• McGettigan JP. 2010. Experimental rabies vaccines for humans. Expert Rev. Vaccines, 9: 1177-1186.
• Mebatsion T, Wiland F, Conzelmann KK. 1999. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol, 73: 242-250.
• Meng S, Sun Y, Wu X. 2011. Evolutionary dynamics of rabies viruses highlights the importance of China rabies transmission in Asia. Virology, 410: 403-409. https://doi.org/10.1016/j.virol.2010.12.011
• Meng S, Xu G, Wu X. 2010. Transmission dynamics of rabies in China over the last 40 years: 1969-2009. J Clin Virol, 49(1): 47-52. https://doi.org/10.1016/j.jcv.2010.06.014
• Mengesha A, Hurisa B, Tesfaye T. 2014. Adaptation of local rabies virus isolates to high growth titer and determination of pathogenicity to develop canine vaccine Ethiopia. J Vaccin Vaccin, 5: 245.
• Meske M, Fanelli A, Rocha F. 2021. Evolution of rabies in South America and inter-species dynamics (2009-2018). Trop Med Infect Dis, 6: 98. https://doi.org/10.3390/tropicalmed6020098
• Miao F, Li N, Yang J, Chen T, Liu Y, Zhang S, Hu R. 2021. Neglected challenges in the control of animal rabies in China. One Health, 12: 100212. https://doi.org/10.1016/j.onehlt.2021.100212
• Ming MF, Teng C, Ye L, Feng ZS, Fei Z, Nan L, Liang HR. 2018. Emerging new phylogenetic groups of rabies virus in Chinese ferret badgers. Biomed. Environ. Sci., 31(6): 479-482. https://doi.org/10.3967/bes2018.064
• Ming P, Du J, Tang Q, Yan J, Nadin-Davis SA, Li H, Tao X, Huang Y, Hu R, Liang G. 2009. Molecular characterization of the complete genome of a street rabies virus isolated in China. Virus Res, 143(1): 6-14. https://doi.org/10.1016/j.virusres.2009.02.014
• Moghadami M, Poormoghaddam A, Kashfi SM. 2017. Epidemiologic study of animal bites and rabies referring to rabies prevention and treatment center of Jahrom university of medical sciences in 2011-2016. J. Human Environ. Health Promot, 2(4): 226-233.
• Montgomery JP, Zhang Y, Well EV, Liu Y, Clayton JL, Wang X, Boulton ML. 2012. Human rabies in Tianjin, China. J Public Health, 2012: 1-7. https://doi.og/10.1093/pubmed/fds041
• Moore SM. 2021. Challenges of rabies serology: Defining context of interpretation. Viruses, 13: 1516. https://doi.org/10.3390/v13081516
• Morimoto K, MsGettigan JP, Foley HD. 2001. Genetic engineering of live rabies vaccines. Vaccine, 19: 3543-3551.
• Muller T, Freuling CM, Wysocki P. 2015. Terrestrial rabies control in the European Union: Historical achievements and challenges ahead. Vet J, 203(1): 10-17. https://doi.org/10.1016/j.tvjl.2014.10.026
• Nadal D, Beeching S, Cleaveland S, Cronin K, Hampson K, Steenson R, Abela-Ridder B. 2022. Rabies and the pandemic: lessons for one health. Trans R Soc Trop Med Hyg, 116: 197-200. https://doi.org/10.1093/trstmh/trab123
• Nandin-Davis SA. 2023. Special issue Advances in Rabies Research. Viruses, 15: 1557. https://doi.org/10.3390/v15071557
• Nishizono A, Yamada K, Khawplod P, Shiota S, Perera D, Matsumoto T, Wimalaratne O, Mitui MT, Ahmed K. 2012. Evaluation of an improved rapid neutralizing antibody detection test (RAPINA) for qualitative and semiquantitative detection of rabies neutralizing antibody in humans and dogs. Vaccine, 30: 3891-3896.
• Oliveira FAS, Castro RJS, Oliveira JFD, Barreto FM, Farias MPO, Marinho CLDOC, Soares MJDS, Silva-Junior A, Schwarz DGG. 2022. Geographical and temporal spread of equine rabies in Brazil. Acta Trop, 227: 106302. https://doi.org/10.1016/j.actatropica.2022.106302
• Osinubi MOV, Wu X, Franka R, Niezgoda M, Nok AJ, Ogunkoya AB, Rupprecht CE. 2009. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications. Vaccine, 27: 7214-7218.
• Perrin P, Jacob Y, Tordo N. 2000. DNA-based immunization against Lyssaviruses. Inter-virol, 43: 302-311.
• Pfaff F, Muller T, Freuling CM. 2019. In-depth genome analyses of viruses from vaccine-derived rabies cases and corresponding live-attenuated oral rabies vaccines. Vaccine, 37: 4758-4765.
• Qi L, Su K, Shen T. 2018. Epidemiological characteristics and post-exposure prophylaxis of human rabies in Chongqing, China, 2007-2016. BMC Infect Dis, 18: 6.
• Qian M-B, Chen J, Bergquist R. 2019. Neglected tropical diseases in the People’s Republic of China: progress towards elimination. Infect Dis Poverty, 8: 86. https://doi.org/10.1186/s40249-019-0599-4
• Qiao Y-C, Wang F, He Y-L, Yang Q, Yang J, Wei Y-S. 2021. Regional and age difference of human rabies prevalence of the past fourteen years in China. Prevent Vet Med, 187: 105161. https://doi.org/10.1016/j.preventmed.2020.105161
• Quiambao BP, Lim JG, Castells VB, Augard C, Petit C, Bravo C, Delore V, Houillon G. 2022. One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety. Vaccine, 40(36): 5347-5355. https://doi.org/10.1016/j.vaccine.2022.07.037
• Rath A, Choudhury S, Batra D, Kapre SV, Rupprecht CE, Gupta SK. 2005. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. Virus Res, 113: 143-152.
• Rattanavipapong W, Thavorncharoensap M, Youngkong S, Genuino AJ, Anothaisintawee T, Chaikledkaew U, Meeyai A. 2019. The impact of transmission dynamics of rabies control: systematic review. Vaccine, 37: A154-A165.
• Recuenco S, Warnock E, Osinubi MOV, Rupprecht CE. 2017. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults. Vaccine, 35: 4315-4320.
• Ren J, Gong Z, Chen E. 2015. Human rabies in Zhejiang province, China. Int J Infect Dis, 38: 77-82. https://doi.org/10.1016/j.ijid.2015.07.013
• Rogee S, Larrous F, Jochmans D. 2019. Pyrimethamine inhibits rabies virus replication in vitro. Antivir Res, 161: 1-9.
• Ruan S. 2017. Modeling the transmission dynamics and control rabies in China. Math Biosci, 286: 65-93. https://doi.org/10.1016/j.mbs.2017.02.005
• Rudd RJ, Smith JS, Yager PA, Orciari LA, Trimarchi CV. 2005. A need for standardized rabies-virus diagnostic procedures: Effect of cover-glass mountant on the reliability of antigen detection by the fluorescent antibody test. Virus Res, 111(1): 83-88. https://doi.org/10.1016/j.virusres.2005.03.014
• Ruppreht CE, Kuzmin IV, Yale G, Nagarajan T, Meslin F-X. 2019. Priorities in applied research to ensure programmatic success in the global elimination of canine rabies. Vaccine, 37: A77-A84.
• Rysava K, Miranda ME, Zapatos R, Lapiz S, Rances P, Miranda LM, Roces MC, Friar J, Townsend SE, Hampson K. 2019. On the path to rabies elimination; the need for risk assessments to improve administration of post-exposure prophylaxis. Vaccine, 37: A64-A72.
• Saffar F, Heinemann M, Heitkamp C, Stelzl DR, Ramharter M, Schnuk M, Rothe C, Buhler S. 2023. Rabies post-exposure prophylaxis of international travellers- Results from two major German travel clinics. Travel Med Infect Dis, 53: 102573. https://doi.org/10.1016/j.tmaid.2023.102573
• Sambo M, Cleaveland S, Ferguson H. 2013. The burden of rabies in Tanzania and its impact on local communities. PLoS Negl Trop Dis, 7(11): e2510.
• Scrima N, Bars RL, Nevers Q. 2023. Rabies virus P protein binds to TBK1 and interferes with the formation of innate immunity-related liquid condensates. Cell Rep, 42(1): 111949. https://doi.org/10.1016/j.celrep.2022.111949
• Seif I, Coulon P, Rollin PE, Flamand A. 1985. Rabies virulence effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol, 53: 926-934.
• Servat A, Wasniewski M, Cliquet F. 2019. Cross-protection of inactivated rabies vaccines for veterinary use against bat lyssaviruses occurring in Europe. Viruses, 11: 936.
• Shafiur Rahaman Kh. 2017. Free roaming dogs: a threat to public health. Int J Epidemiol Res, 4(3): 182-184.
• Shahrabian MH, Kuang Y, Cui H et al. 2023. Metabolic changes of active components of important medicinal plants on the basis of traditional Chinese medicine under different environmental stresses. Curr Org Chem, 27(9): 782-806.
• Shahrajabian MH, Sun W, Cheng Q. 2020. Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly disases, from SARS to SARS-CoV-2. Hum. Vaccines Immunother, 17(1): 62-83. https://doi.org/10.1080/21645515.2020.1797369
• Shahrajabian MH, Sun W, Cheng Q. 2021. Different methods for molecular and rapid detection of human novel coronavirus. Curr Pharm Des, 27: 1-10. https://doi.org/10.2174/1381612827666210604114411
• Shahrajabian MH, Sun W, Soleymani A, Cheng Q. 2020. Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses. Phytother Res, 2020(1): 1-11. https://doi.org/10.1002/ptr.6888
• Shahrajabian MH, Sun W. 2023. Mechanism of action of collagen and epidermal growth factor: A review on theory and research methods. Mini-Rev Med Chem, 24(4): e160823219749 . https://doi.org/10.2174/1389557523666230816090054
• Shahrajabian MH, Sun W. 2023. Study of different types of fermentation in wine-making process and considering aromatic substances and organic acid. Curr Org Synth, 20: e030823219388. https://doi.org/10.2174/1570179420666230803102253
• Shahrajabian MH, Sun W. 2023. Various techniques for molecular and rapid detection of infectious and epidemic diseases. Lett Org Chem, 20(9): 779-801. https://doi.org/10.2174/1570178620666230331095720
• Shen Q, Zhang J, Hou YX. 2018. Quality control of the agricultural products supply chain based on “Internet +”. Inform Process Agri, 5: 394-400.
• Shi W, Kou Y, Xiao J, Zhang L, Gao F, Kong W, Su W, Jiang C, Zhang Y. 2018. Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants. Vaccine, 36: 5020-5029.
• Shoemaker SR, Li TX, Wu W, Pak JE, Marqusee S. 2023. Exploring the conformational landscape of the rabies virus glycoprotein using HDX-MS. Biophys J, 122(3): 189. https://doi.org/10.1016/j.bpj.2022.1.1162
• Si H, Guo Z-M, Hao YT, Liu Y-G, Zhang D-M, Rao S-Q, Lu J-H. 2008. Rabies trend in China (1990-2007) and post-exposure prophylaxis in the Guangdong province. BMC Infect Dis, 8: 1-10.
• Song M, Tang Q, Rayner S. 2014. Human rabies surveillance and control in China, 2005-2012. BMC Infect Dis, 14: 212.
• Song M, Tang Q, Wang DM. 2009. Epidemiological investigations of human rabies in China. BMC infect Dis, 9: 210.
• Su X, Pei Z, Hu S. 2014. Ginsenoside Re as an adjuvant to enhance the ummune response to the inactivated rabies virus vaccine in mice. Int Immunopharmacol, 20: 283-289.
• Sultan F, Khan A. 2013. Infectious diseases in Pakistan: a clear and present danger. Lancet, 381(9884): 2138-2140.
• Sun W, Shahrajabian MH, Cheng Q. 2021. Natural dietary and medicinal plants with anti-obesity therapeutics activities for treatment and prevention of obesity during lock down and in post-covid-19 era. Appl Sci, 11(17): 7889. https://doi.org/10.3390/app11177889
• Sun W, Shahrajabian MH, Lin M. 2022. Research progress of fermented functional foods and protein factory-microbial fermentation technology. Fermentation, 8(12): 688. https://doi.org/10.3390/fermentation8120688
• Tao X, Liu S, Zhu W, Rayner S. 2021. Rabies surveillance and control in China over the last twenty years. Biosaf Health, 3: 142-147. https://doi.org/10.1016/j.bsheal.2020.11.004
• Tarantola A, Tejiokem MC, Briggs DJ. 2019. Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines. Vaccine, 37: A88-A93.
• Taxitiemuer A, Tuerdi G, Zhang Y, Wushouer F, Tao XY, Talipu J, Yimamu T, Ma HL. 2017. An investigation of the first case of human rabies caused by a fox in China in May 2016. Biomed Environ Sci, 30(11): 825-828. https://doi.org/10.3967/bes2017.110
• Tierradentro-Garcia L, Cortes-Albornoz MC, Talero-Gutierrez C. 2022. Of love and other demons: depicting human rabies in Colombia. Heliyon, 8(6): e09703. https://doi.org/10.1016/j.heliyon.2022.e09703
• Tsiodras S, Korou L-M, Tzani M, Tasioudi KE, Kalachanis K, Mangana-Vougiouka O, Rigakos G, Dougas G, Seimenis Am, Kontos V. 2014. Rabies in Greece; historical perspectives in view of the current re-emergence in wild and domestic animals. Travel Med Infect Dis, 12(6): 628-635. https://doi.org/10.1016/j.tmaid.2014.01.013
• Undurraga EA, Millien MF, Allel K, Etheart MD, Cleaton J, Ross Y. 2020. Vaccine Evaluation Team; Wallace, R.M. Costs and effectiveness of alternative dog vaccination strategies to improve dog population coverage in rural and urban settings during a rabies outbreak. Vaccine, 38(39): 6162-6173. https://doi.org/10.1016/j.vaccine.2020.06.006
• Walker PJ, Kongsuwan K. 1999. Deduced structural model for animal rhabdovirus glycoproteins. J Gen Virol, 80(Pt 5): 1211-1220.
• Wambura G, Mwatondo A, Muturi M, Nasimiyu C, Wentworth D, Hampson K, Bichanga P, Tabu C, Juma S, Ngere I, Thumbi SM. 2019. Rabies vaccine and immunoglobulin supply and logistics: challenges and opportunities for rabies elimination in Kenya. Vaccine, 37: A28-A34.
• Wang DL, Zhang XF, Jin H, Chen XQ, Duan CX, Wang XC, Bao CJ, Zhou MH, Ahmad T. 2018. Post-exposure prophylaxis vaccination rate and risk factors of human rabies in mainland China: a meta-analysis. Epidemiol Infect, 147: 1-6. https://doi.org/10.1017/S095026881800.175
• Wang L, Tang Q, Liang G. 2014. Rabies and rabies virus in wildlife in mainland China, 1990-2013. Int J Infect Dis, 25: 122-129. https://doi.org/10.1016/j.ijid.2014.04.016
• Wang L, Zhang J, Meng S, Ge L, You Y, Xu Q, Wang H, Yang J, Wang S, Wu H. 2022. Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis. Vaccine, 40(32): 4371-4379. https://doi.org/10.1016/j.vaccine.2022.06.035
• Wang W, Ni Y, Gao K, Lu Q, Li X. 2013. Spontaneous pneumomediastinum due to paralytic rabies. Brazil J Infect Dis, 17(1): 94-96.
• Wang X, Fang Z, Xiong J, Yang K, Chi Y, Tang X, Ma L, Zhang R, Deng F, Lan K, Zhou D. 2019. A chimpanzee adenoviral vector-based vaccine protects beagle dogs from lethal rabies virus challenge. Virology, 536: 32-38.
• Ward MP, Brookes VJ. 2021. Rabies in our neighbourhood: preparedness for an emerging infectious diseases. Pathogens, 10: 375. https://doi.org/10.3390/pathogens10030375
• Warrell M. 2010. Rabies and African bat lyssavirus encephalitis and its prevention. Int J Antimicrob Agents, 36: S47-S52.
• Whitehouse ER, Mandra A, Bonwitt J, Beasley EA, Taliano J, Rao AK. Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposures. Lancet Infect Dis, 23(5): e167-e174. https://doi.org/10.1016/S1473-3099(22)00641-7
• Wijaya L, Tham CYL, Chan YFZ, Wong AWL, Wang L-F, Bertoletti A, Low JG. 2017. An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers. Vaccine, 35: 1175-1183.
• Wiktor T. 1985. Historical aspects of rabies treatment. Koprowski H, Plotkin SA (editors), World’s Debt to Pasteur. Alan R. Liss, New York, US, pp: 141-151.
• Winkler WG. 1975. Fox rabies. In: Baer G (editor). The natural history of rabies. Academic Press, New YorkUS, pp: 3-22.
• Woldehiwet Z. 2002. Rabies: recent developments. Res Vet Sci, 73: 17-25.
• Wolelaw GA, Yalew WA, Azene AG, Wassie GT. 2022. Rabies prevention practices and associated factors among household heads in Bure Zuria district, North West Ethiopia. Sci Rep, 12: 7361. https://doi.org/10.1038/s41598-022-10863-z
• Won YL, Ko KS, Park JO, Choi JO, Lee H, Sung J-M, Lee M-Y. 2019. Achievements, problems, and future direction of the quality control program for special periodic health examination agencies in Republic of Korea. Saf Health Work, 10: 125-129.
• Wu H, Wang L, Tao X, Li H, Rayner S, Liang G, Tang Q. 2013. Genetic diversity and molecular evolution of the rabies matrix protein gene in China. Infect Genet Evol, 16: 248-253.
• Wu X, Franka R, Svoboda P, Pohl J, Rupprecht CE. 2009. Development of combined vaccines for rabies and immunocontraception. Vaccine, 27: 7202-7209.
• Wunner WH, Larson JK, Dietzschold B, Smith CL (1988) The molecular biology of rabies viruses. Rev Infect Dis, 10(4): S771-784.
• Wunner WH. 2007. Rabies virus. In: Jackson AC, Wunner WH (eds.) Rabies. Academic Press, San Diego, US, pp: 23-68.
• Xing C, Zhang Z, Jiang Q-W. 2014. Analysis on phosphoprotein and matrixprotein gene of rabies virus in Henan Province, China. Int J Infect Dis, 21(1): 187. https://doi.org/10.1016/j.ijid.2014.03.811
• Xu M, Liang Z, Xu Y, Wang J. 2015. Chinese vaccine products go global: vaccine development and quality control. Expert Rev Vaccine, 14(5): 763-773.
• Yale G, Lopes M, Isloor S, Head JR, Mazeri S, Gamble L, Dukpa K, Gongal G, Gibson. 2022. Review of oral rabies vaccination of dogs and its application in India. Viruses, 14: 155. https://doi.org/10.3390/v14010155
• Yang L, Cen J, Xue Q, Li J, Bi Y, Sun L, Liu W. 2013. Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG. Virus Res, 174: 47-51.
• Yang ZW, Dong LG. 2012. Current status of canine rabies in China. Biomed Environ Sci, 25(5): 602-605.
• Yin CP, Zhou H, Wu H, Tao X-Y, Rayner S, Wang S-M, Tang Q, Liang G-D. 2012. Analysis on factors related to rabies epidemic in China from 2007-2011. Virol Sinica, 27(2): 132-143.
• Yin W, Dong J, Tu C, Edwards J, Guo F, Zhou H, Yu H, Vong S. 2013. Challenges and needs for China to eliminate rabies. Infect Dis Poverty, 2: 23. https://doi.org/10.1186/2049-9957-2-23
• Yu GK, Li MD, Peng JY. 1995. Clinical characterization of human rabies caused by cats. Chin J Zoonoses, 11(3): 62-63.
• Zhai L-L, Wang H, Zhao W, Zhang SF, Miao FM, Cao Y, Chen C, Li YF, Gao J, Lv RY, Zhang SX, Cao JB, Zhang XF, Yang MM, Zhang B, Zhao J, Wei JS, Gao J. 2022. Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models. Travel Med Infect Dis, 46: 102267. https://doi.org/10.1016/j.tmaid.2022.102267
• Zhang F, Liu Y, Zhang SF. 2006. Survey of neutralizing antibody against in dogs in China cities and suburbs. China J Vet Sci, 26(6): 634-636.
• Zhang J, Han Q, Song Y, Chen Q, Xia X. 2015. Analysis of subcellular prefoldin 1 redistribution during rabies virus infection. Jundishapur J Microbiol, 8(7): e24757.
• Zhang J, Jin Z, Sun G-Q, Zho T, Ruan S. 2011. Analysis of rabies in China: Transmission dynamics and control. Plos One, 6(7): e20891. https://doi.org/10.1371/journal.pone.0020891
• Zhang S, Liu Y, Hou Y, Zhao J, Zhang F, Wang Y, Hu R. 2013. Epidemic and maintenance of rabies in Chinese ferret badgers (Melogale moschata) indicated by epidemiology and the molecular signatures of rabies viruses. Virol Sin, 28(3): 146-151.
• Zhang S, Tang Q, Wu X, Liu Y, Zhang F, Rupprecht CE, Hu R. 2009. Rabies in ferret badgers, southeastern China. Emerg Infect Dis, 15(6): 946-949. https://doi.oorg/10.3201/eid1506.081485
• Zhang W, Zheng X, Cheng N, Gai W, Xue X, Wang Y, Gao Y, Shan J, Yang S, Xia X. 2016. Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine. Int J Biol Macromol, 87: 7-15.
• Zhang Y, Zhang S, Li W, Hu Y, Zhao J, Liu F, Lin H, Liu Y, Wang L, Xu S, Hu R, Shao H, Li L. 2016. A novel rabies vaccine based on toll like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies. Virology, 489: 165-172.
• Zhang Y-Z, Xiong C-L, Lin X-D, Zhou DJ, Jiang RJ, Xiao QY, Xie XY, Yu XX, Tan YJ, Li MH, Ai QS, Zhang LJ, Zou Y, Huang C, Fu ZF. 2009 Genetic diversity of Chinese rabies viruses: Evidence for the presence of two distinct clades in China. Infect Genet Evol, 9(1): 87-96. https://doi.org/10.1016/j.meegid.2008.10.014
• Zhang YZ, Xiong CL, Xiao DL, Jiang RJ, Wang ZX, Zhang LZ, Fu ZF. 2005. Human rabies in China. Emerg Infect Dis, 11(12): 1983-1984.
• Zhang Y-Z, Xiong C-L, Zou Y, Wang D-M, Jiang R-J, Xiao Q-Y, Hao Z-Y, Zhang L-Z, Yu Y-X, Fu ZF. 2006. Molecular characterization of rabies virus isolates in China during 2004. Virus Res, 121(2): 179-188. https://doi.org/10.1016/j.virusres.2006.05.010
• Zhang YZ, Xiong CL, Zou Y, Wang DM, Yu C, Zhou JZ, Wang ZX, Zhang YR, Zhen F. 2006. An epidemiological study of rabies in Anlong County of Guizhou Province. Virol Sinica, 21(4): 394-400.
• Zhang Z, Xiong C, Jiang Q-W. 2014. Survey on rabies virus carried by domestic dogs in Henan and Shaanxi Province, China. Int J Infect Dis, 21(1): 186. https://doi.org/10.1016/j.ijid.2014.03.809
• Zhao H, Zhang J, Cheng C, Zhou YH. 2019. Rabies acquired through mucosal exposure, China, 2013. Emerg Infect Dis, 25(5): 1028-1029. https://doi.org/10.3201/eid2505.181413
• Zhao J, Liu Y, Zhang S, Zhang F, Wang Y, Mi L, Wang S, Hu R. 2014. Molecular characterization of three ferret badger (Melogale moschata) rabies virus isolates from Jiangxi province, China. Arch Virol, 159(8): 2059-2067.
• Zhao J, Ma SC, Li SP. 2018. Advanced strategies for quality control of Chinese medicines. J Pharm Biomed Anal, 147: 473-478.
• Zhao R, Shan Y, Li M et al. 2020. Novel strategy for expression and characterization of rabies virus glycoprotein. Protein Express Purif, 168: 105567.
• Zhou H, Li Y, Chen RF, Tao XY, Yu PC, Cao SC, Li L, Chen ZH, Zhu WY, Yin WW, Li YH, Wang CL, Yu HJ, Chinese Center for Disease Control and Prevention. 2016. Technical guideline for human rabies prevention and control. Zhonghua Liu Xing Bing Xue Za Zhi, 37: 139-163.
• Zhu H, Chen X, Shao X, Ba H, Wang F, Wang H, Yang Y, Sun N, Ren J, Cheng S, Wen Y. Characterization of a virulent dog-originated rabies virus affecting more than twenty fallow deer (Dama dama) in Inner Mongolia, China. Infect Genet Evol, 31: 127-134. https://doi.org/10.1016/j.meegid.2014.12.024